HADHA promotes esophageal cancer progression by activating mTOR signaling and the SP1/MDM2 axis
Acta Biochimica et Biophysica Sinica · 2025
DOI: 10.3724/abbs.2024139 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2025. Verfasst von Xusheng Ding und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai 200032, China. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Esophageal Neoplasms, Proto-Oncogene Proteins c-mdm2, Sp1 Transcription Factor. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Esophageal cancer (EC) is one of the most recalcitrant cancers, with a 5-year survival rate of < 30%. The hydroxyacyl-CoA dehydrogenase alpha subunit (HADHA) plays an essential role in long-chain fatty acid metabolism, and dysregulation of HADHA has been demonstrated to be involved in a series of metabolic diseases and cancers. However, its role in cancers remains controversial. HADHA has seldom been investigated in EC, and little is known about how HADHA regulates the malignant progression of EC. In this study, we find that HADHA is significantly upregulated in EC tissues and is correlated with poor survival. HADHA knockdown markedly inhibits EC cell proliferation both in vitro and in vivo. The loss of HADHA also induces EC cell apoptosis, causes cell cycle arrest and inhibits cell migration. Additionally, RNA profiling reveals that mTOR signaling is significantly suppressed after HADHA knockdown. Mechanistically, HADHA interacts with SP1 and induces MDM2 expression. In conclusion, both mTOR signaling and the SP1-MDM2 axis participate in the HADHA-induced malignant behavior of EC cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
- Institute of Thoracic Oncology, Fudan University, Shanghai 200032, China.
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
- Department of Thoracic Surgery, Fudan University Shanghai Cancer Center Xiamen Hospital, Xiamen 361026, China.
Zitieren
APA
Ding, X., Shao, L., Wang, J., Jin, Y., Chen, H., & Li, B. (2025). HADHA promotes esophageal cancer progression by activating mTOR signaling and the SP1/MDM2 axis. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2024139
Vancouver
Ding X, Shao L, Wang J, Jin Y, Chen H, Li B. HADHA promotes esophageal cancer progression by activating mTOR signaling and the SP1/MDM2 axis. Acta Biochimica et Biophysica Sinica. 2025. doi:10.3724/abbs.2024139
BibTeX
@article{Ding2025,
author = {Ding, Xusheng and Shao, Longlong and Wang, Jie and Jin, Yongwei and Chen, Haiqing and Li, Bin},
title = {HADHA promotes esophageal cancer progression by activating mTOR signaling and the SP1/MDM2 axis},
journal = {Acta Biochimica et Biophysica Sinica},
year = {2025},
doi = {10.3724/abbs.2024139}
}
EUVIMED